Taysha Gene Therapies Inc
(NAS:TSHA)
$
5.02
-0.14 (-2.71%)
Market Cap: 1.64 Bil
Enterprise Value: 1.24 Bil
PE Ratio: 0
PB Ratio: 4.22
GF Score: 33/100 Taysha Gene Therapies Inc (TSHA) Transcripts
- 1